| Literature DB >> 35409805 |
Yangyang Cui1,2,3, Hankun Zhang1,3, Jia Zhu1,2,3, Zhenhua Liao3, Song Wang3, Weiqiang Liu1,2,3.
Abstract
BACKGROUND: Saliva has been studied as a better indicator of disorders and diseases than blood. Specifically, the salivary glucose level is considered to be an indicator of diabetes mellitus (DM). However, saliva collection methods can affect the salivary glucose level, thereby affecting the correlation between salivary glucose and blood glucose. Therefore, this study aims to identify an ideal saliva collection method and to use this method to determine the population and individual correlations between salivary glucose and blood glucose levels in DM patients and healthy controls. Finally, an analysis of the stability of the individual correlations is conducted.Entities:
Keywords: blood glucose; correlation; diabetes mellitus; saliva collection method; salivary glucose
Mesh:
Substances:
Year: 2022 PMID: 35409805 PMCID: PMC8999001 DOI: 10.3390/ijerph19074122
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Six methods for collecting saliva samples, (a) UWS/SWS: the swab in the test tube was taken out and put in the mouth to chew for 3 min, (b) USS/SSS: the swab was put under the tongue and it was taken out after 3 min, (c) UPS/SPS: the swab was placed near the left parotid duct and it was taken out after 3 min.
Saliva flow rate of the studied groups (DM patient/control and stimulated/unstimulated).
| Salivary Flow | Patients ( | Controls ( | ||
|---|---|---|---|---|
| Male | Female | Male | Female | |
| UWS | 0.85 ± 0.18 | 0.85 ± 0.11 | 1.64 ± 0.16 | 0.89 ± 0.09 |
| SWS | 1.73 ± 0.12 | 1.52 ± 0.13 | 2.28 ± 0.15 ** | 1.78 ± 0.12 |
| UPS | 0.44 ± 0.09 | 0.43 ± 0.11 * | 0.82 ± 0.08 | 0.45 ± 0.07 |
| SPS | 1.05 ± 0.09 | 0.91 ± 0.03 | 1.16 ± 0.08 | 0.91 ± 0.06 |
| USS | 0.72 ± 0.11 | 0.71 ± 0.09 | 1.41 ± 0.12 | 0.76 ± 0.08 |
| SSS | 1.47 ± 0.04 | 1.31 ± 0.33 | 1.94 ± 0.09 | 1.51 ± 0.14 |
** Maximum saliva flow. * Minimum saliva flow. UWS: unstimulated whole saliva, SWS: stimulated whole saliva, USS: unstimulated sublingual/submandibular saliva, SSS: stimulated sublingual/submandibular saliva, SPS: stimulated parotid saliva, UPS: unstimulated parotid saliva.
The average levels of saliva glucose for each group (DM patient/control and stimulated/unstimulated).
| Glucose Levels (mM) | SWS | UWS | SPS | UPS | SSS | USS |
|---|---|---|---|---|---|---|
| Patients ( | 1.53 ± 0.63 | 2.42 ± 0.66 | 1.84 ± 0.64 | 2.89 ± 0.76 ** | 1.79 ± 0.63 | 2.58 ± 0.52 |
| Controls ( | 1.42 ± 0.60 * | 1.43 ± 0.40 | 1.50 ± 0.53 | 1.49 ± 0.49 | 1.54 ± 0.54 | 1.82 ± 0.31 |
** Maximum level of saliva glucose. * Minimum level saliva glucose. UWS: unstimulated whole saliva, SWS: stimulated whole saliva, USS: unstimulated sublingual/submandibular saliva, SSS: stimulated sublingual/submandibular saliva, SPS: stimulated parotid saliva, UPS: unstimulated parotid saliva.
Figure 2Salivary glucose levels in all participants, (a) DM patient group, (b) Healthy control group.
Figure 3The ROC curve of salivary glucose in the diagnosis of DM of six saliva collection methods.
Figure 4Correlation between salivary glucose of six saliva collection method and blood glucose. (a) The correlation between SWS glucose with blood glucose (R2 = 0.001127, Sy. x = 0.6183), (b) The correlation between UWS glucose with blood glucose (R2 = 0.8109, Sy. x = 0.3217), (c) The correlation between SPS glucose with blood glucose (R2 = 0.1568, Sy. x = 0.5597), (d) The correlation between UPS glucose with blood glucose (R2 = 0.9153 (maximum correlation), Sy. x = 0.2772), (e) The correlation between SSS glucose with blood glucose (R2 = 0.05544, Sy. x = 0.5844), (f) The correlation between USS glucose with blood glucose (R2 = 0.8492, Sy. x = 0.2236). Sy. x means standard error of estimate (also seen as SEE).
Figure 5Correlation coefficients before and after meal of each group include DM patients and healthy controls, the Correlation refers to the correlation between blood and saliva glucose, and No. refers to the number of participants.
Weekly correlation coefficient between DM patients and control group within one month.
| No. | Patients ( | No. | Controls ( | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 w | 2 w | 3 w | 4 w | CV % | 1 w | 2 w | 3 w | 4 w | CV % | ||
| 1 | 0.93 | 0.89 | 0.94 | 0.89 | 2.8 | 1 | 0.91 | 0.89 | 0.87 | 0.83 | 3.9 |
| 2 | 0.92 | 0.87 | 0.89 | 0.91 | 2.4 | 2 | 0.82 | 0.81 | 0.79 | 0.76 | 3.3 |
| 3 | 0.86 | 0.87 | 0.85 | 0.82 | 2.5 | 3 | 0.88 | 0.87 | 0.83 | 0.81 | 3.8 |
| 4 | 0.91 | 0.86 | 0.92 | 0.87 | 3.3 | 4 | 0.76 | 0.75 | 0.77 | 0.72 | 2.8 |
| 5 | 0.88 | 0.91 | 0.89 | 0.93 | 2.4 | 5 | 0.84 | 0.83 | 0.79 | 0.78 | 3.6 |
| 6 | 0.84 | 0.75 | 0.83 | 0.81 | 4.9 | 6 | 0.68 | 0.67 | 0.65 | 0.68 | 2.1 |
| 7 | 0.89 | 0.84 | 0.88 | 0.85 | 2.7 | 7 | 0.66 | 0.65 | 0.68 | 0.61 | 4.5 |
| 8 | 0.87 | 0.87 | 0.86 | 0.83 | 2.2 | 8 | 0.76 | 0.75 | 0.69 | 0.77 | 4.8 |
| 9 | 0.92 | 0.84 | 0.91 | 0.88 | 4.0 | 9 | 0.72 | 0.71 | 0.65 | 0.67 | 4.8 |
| 10 | 0.81 | 0.83 | 0.86 | 0.78 | 4.1 | 10 | 0.66 | 0.65 | 0.59 | 0.64 | 4.8 |